04.04.2016
- In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical...
02.12.2014
- Siegfried Group has acquired Hameln Pharma in Germany, consisting of Hameln Pharmaceuticals and Hameln RDS, with effect from end November 2014. Hameln Pharma is located in the city...
09.08.2010
- Hameln Pharma, part of Hameln Group, has been focusing on the development, production and distribution of pharmaceuticals for over 50 years. Specialising in the contract...
